Long-term sequelae of Helicobacter pylori gastritis. 1995

E J Kuipers, and A M Uyterlinde, and A S Peña, and R Roosendaal, and G Pals, and G F Nelis, and H P Festen, and S G Meuwissen
Department of Gastroenterology, Free University Hospital, Amsterdam, Netherlands.

Chronic Helicobacter pylori gastritis has been put forward as a risk factor for development of gastric mucosal atrophy and gastric cancer. The purpose of our study was to investigate the long-term effects of H pylori gastritis on the gastric mucosa. We prospectively studied 49 subjects negative for H pylori and 58 positive subjects for a mean follow-up of 11.5 years (range 10-13 years). Serum samples were obtained at the initial and follow-up visits for determination of H pylori IgG antibodies. Gastroscopies with biopsy sampling were done in all patients at both visits. Biopsy specimens were used for assessment of H pylori infection and histology. Development of atrophic gastritis and intestinal metaplasia occurred in 2 (4%) uninfected and 16 (28%) infected subjects. Regression of atrophy was noted in 4 (7%) infected subjects. Development of atrophic gastritis and intestinal metaplasia was significantly associated with H pylori infection (p = 0.0014; odds ratio 9.0, 95% CI 1.9-41.3). The proportion of atrophic gastritis in the study population showed an annual increase of 1.15% (0.5-1.8%). We conclude that H pylori infection is a significant risk factor for development of atrophic gastritis and intestinal metaplasia. Our findings support strongly the causative role of this infection in gastric carcinogenesis.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007422 Intestines The section of the alimentary canal from the STOMACH to the ANAL CANAL. It includes the LARGE INTESTINE and SMALL INTESTINE. Intestine
D008297 Male Males
D008679 Metaplasia A condition in which there is a change of one adult cell type to another similar adult cell type.
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010437 Peptic Ulcer Ulcer that occurs in the regions of the GASTROINTESTINAL TRACT which come into contact with GASTRIC JUICE containing PEPSIN and GASTRIC ACID. It occurs when there are defects in the MUCOSA barrier. The common forms of peptic ulcers are associated with HELICOBACTER PYLORI and the consumption of nonsteroidal anti-inflammatory drugs (NSAIDS). Gastroduodenal Ulcer,Marginal Ulcer,Gastroduodenal Ulcers,Marginal Ulcers,Peptic Ulcers,Ulcer, Gastroduodenal,Ulcer, Marginal,Ulcer, Peptic,Ulcers, Gastroduodenal,Ulcers, Marginal,Ulcers, Peptic
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

E J Kuipers, and A M Uyterlinde, and A S Peña, and R Roosendaal, and G Pals, and G F Nelis, and H P Festen, and S G Meuwissen
August 1995, Lancet (London, England),
E J Kuipers, and A M Uyterlinde, and A S Peña, and R Roosendaal, and G Pals, and G F Nelis, and H P Festen, and S G Meuwissen
January 1997, Journal of clinical gastroenterology,
E J Kuipers, and A M Uyterlinde, and A S Peña, and R Roosendaal, and G Pals, and G F Nelis, and H P Festen, and S G Meuwissen
April 2002, Digestive diseases and sciences,
E J Kuipers, and A M Uyterlinde, and A S Peña, and R Roosendaal, and G Pals, and G F Nelis, and H P Festen, and S G Meuwissen
January 1997, Irish journal of medical science,
E J Kuipers, and A M Uyterlinde, and A S Peña, and R Roosendaal, and G Pals, and G F Nelis, and H P Festen, and S G Meuwissen
January 2023, Gut,
E J Kuipers, and A M Uyterlinde, and A S Peña, and R Roosendaal, and G Pals, and G F Nelis, and H P Festen, and S G Meuwissen
February 1998, Alimentary pharmacology & therapeutics,
E J Kuipers, and A M Uyterlinde, and A S Peña, and R Roosendaal, and G Pals, and G F Nelis, and H P Festen, and S G Meuwissen
October 2005, Scandinavian journal of gastroenterology,
E J Kuipers, and A M Uyterlinde, and A S Peña, and R Roosendaal, and G Pals, and G F Nelis, and H P Festen, and S G Meuwissen
July 1991, The British journal of general practice : the journal of the Royal College of General Practitioners,
E J Kuipers, and A M Uyterlinde, and A S Peña, and R Roosendaal, and G Pals, and G F Nelis, and H P Festen, and S G Meuwissen
June 1992, Digestive diseases and sciences,
E J Kuipers, and A M Uyterlinde, and A S Peña, and R Roosendaal, and G Pals, and G F Nelis, and H P Festen, and S G Meuwissen
April 1997, Journal of gastroenterology,
Copied contents to your clipboard!